Kissei Pharmaceutical Co., which sells Amgen Inc.’s drug Tavneos in Japan, is recommending that doctors stop prescribing it, ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Investors in Amgen Inc. AMGN need to pay close attention to the stock based on moves in the options market lately. That is ...

Moby Strategic Performance and Portfolio Evolution. Management characterizes 2026 as a 'springboard year' where rapid growth ...

The district court denied Amgen’s motion to dismiss on February 10, 2023, concluding that Regeneron sufficiently alleged state and federal antitrust claims, such as “anticompetitive conduct under an ...

View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Amgen reported 2Q revenue of $9.2bn and non-GAAP EPS of $6.02, topping expectations. The company raised its 2025 revenue and earnings guidance. See the seasonal trading strategy that's beating the S&P ...

On July 16, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a settlement agreement between Amgen, Inc. (“Amgen”) and Accord BioPharma, Inc.

Thousand Oaks pharma giant Amgen Inc. is making a series of C-suite changes, triggered by the retirement announcement of ...

Amgen's two patent applications purporting to cover all antibodies that bind and block the PCSK9 receptor involved in LDL cholesterol metabolism fail to satisfy the Patent Act's enablement clause, ...